VANCOUVER, British Columbia–(BUSINESS WIRE)–#AI–As artificial intelligence (AI) technologies continue to rapidly evolve and integrate into critical business operations, CPSI Certifications is pleased to announce the official launch of its ISO/IEC 42001:2023 certification services. This new offering supports organizations in implementing robust AI governance frameworks aligned with international best practices. ISO/IEC 42001:2023 is the first globally … [Read more…]

BOISE, Idaho–(BUSINESS WIRE)–#BehavioralHealth–DaysToHappy today announced the launch of Happy 2.0, a revolutionary mental health platform designed to help HR leaders and university administrators address rising rates of depression and anxiety among employees and students—at scale, and without overburdening traditional mental health systems. Built for today’s fast-moving organizations and campuses, Happy 2.0 combines AI-driven mental health … [Read more…]

BOSTON–(BUSINESS WIRE)–#biosciences–Mispro has announced the opening of its eighth Boston-area contract vivarium, located at Southline Boston in Dorchester—reinforcing its role as the region’s most deeply embedded and consistently scaled vivarium space and services provider. Located within Southline’s 700,000+ square foot life sciences campus, the new facility expands Mispro’s support for early- and growth-stage biotechs across … [Read more…]

Systemic Sclerosis (SSc) is a life-threatening autoimmune disease that causes severe inflammation and fibrosis, while Chronic Pruritus of Unknown Origin (CPUO) is characterized by a persistent, chronic itch with an unknown cause1-3 Nemolizumab is the first approved monoclonal antibody that specifically targets the IL-31 receptor alpha, inhibiting the signaling of IL-31. It is approved for … [Read more…]

DALLAS–(BUSINESS WIRE)–Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of common stock. In addition, Forte expects to grant … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–A new investigative report from HIPAA compliant email provider Paubox has exposed a hidden security failure in Microsoft 365 and Google Workspace, two of the most widely used email platforms. Despite claims of encryption and compliance, both platforms fail under real-world conditions that could expose sensitive information without the sender or receiver knowing. … [Read more…]

MOUNT PROSPECT, Ill.–(BUSINESS WIRE)–Rauland®, a global leader in healthcare clinical communications and workflow solutions and a subsidiary of AMETEK, Inc., today announced the expansion of its Vendor Integration Partner (VIP) Program to include leading virtual care platforms Artisight, hellocare.ai, and NESA. This strategic advancement reaffirms Rauland’s commitment to shaping a more connected and responsive healthcare … [Read more…]

Promega Tailored R&D Solutions (TRS) services are now listed on Scientist.com and Science Exchange. These platforms streamline access to customized Promega technologies and R&D collaboration. TRS is a collaborative partner that works with drug discovery researchers to build bespoke solutions to unique problems and perform screening services.   MADISON, Wis.–(BUSINESS WIRE)–Promega Tailored R&D Solutions (TRS) … [Read more…]

The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile The launch strengthens Zambon’s presence in China and marks a significant step in the company’s commitment to global therapeutic innovation in respiratory diseases, reflecting its dedicated focus on both clinical research and patient care … [Read more…]

FUJISAWA, Japan & BOSTON–(BUSINESS WIRE)–Axcelead Drug Discovery Partners, Inc. (Axcelead DDP) and Superluminal Medicines, Inc. (Superluminal) announced the intention to collaborate on drug discovery targeting specific molecular mechanisms associated with challenging biological targets. The two companies have built a strong relationship through prior collaborations. Axcelead DDP provided high-quality in vivo pharmacological evaluations of proprietary compounds … [Read more…]